search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Company insight


Overcome complex challenges with the right CDMO


In a constantly evolving and increasingly complex landscape of medical device manufacturing, selecting the right CDMO is a critical decision to ensure the success of your product’s life cycle. With over 60 years of experience and expertise, from discovery to delivery, Phillips Medisize has the capabilities to effectively manage a collaborative process that drives innovation from your product.


ontract development and manufacturing organisations (CDMOs) offer specialised knowledge and experience in device design, engineering and manufacturing. This process often facilitates exciting opportunities for industry and product innovation. Outsourcing to a CDMO helps medical companies save valuable resources by leveraging the CDMO’s comprehensive expertise to overcome complex technical challenges and develop cutting-edge solutions that comply with the necessary regulations. In a constantly evolving and highly regulated landscape, selecting the right CMDO is a critical decision that impacts the life cycle, safety and success of your product. Phillips Medisize, a Molex company, plays a critical enabling role by addressing the toughest challenges faced by medtech companies and capitalising on emerging opportunities with engineering knowledge and experience. The company offers platform products like connectors and cable assemblies, allowing customers to access advanced, customisable solutions without the full burden of a new design or redesign. “Our engineers collaborate closely with customers to solve development challenges and accelerate the commercialisation of new products. We deliver next-generation medical devices that are differentiated, smart, safe and designed to enhance and save lives,” says Pete Soupir, VP and segment lead of medtech at Molex. “This is exemplified in our capabilities around miniaturisation, including the use of fibre, copper and interconnects in catheter applications, as well as optimising manufacturing processes to ensure products can be commercialised efficiently.”


C


Understand the product life cycle Ensuring a seamless transition from R&D to manufacturing is crucial for the successful commercialisation of medtech devices. The use of cross-functional teams, comprising experts from R&D, engineering, quality assurance and manufacturing, ensures that all aspects of product development are considered from the outset. This collaborative approach helps identify potential challenges early and develop solutions that are feasible for both design and production.


“Our deep expertise in R&D is a cornerstone of who we are – we have seven R&D centres across three continents,” adds Soupir. “We are equipped with cutting-edge research facilities and a team of seasoned professionals who excel in developing innovative medtech solutions. This focus on R&D ensures that our customers have access to the latest technologies and methodologies.” Applying design for manufacturability (DfM) principles during the R&D phase ensures that products are designed with manufacturing efficiency in mind. This foresight minimises the need for redesigns and helps streamline the transition to full- scale production.


Navigate the medtech landscape Phillips Medisize offers in-depth knowledge of the medtech landscape, helping businesses effectively navigate trends, regulations and technologies. Its expertise covers the entire product life cycle, from design to commercialisation, ensuring smooth integration at every stage. For one CGM customer, the human-centred design approach Phillips Medisize took –


Medical Device Developments / www.medicaldevice-developments.com


examining product usefulness, usability, desirability and manufacturability – proved invaluable in streamlining product design, which helped accelerate innovation and the expedited development of ten product iterations over two years.


“Involving us early in the planning and strategy development stages ensures that insights and expertise are incorporated into project plans. This joint approach can identify potential challenges and opportunities, optimising the development pathway,” says Kevin Ennett, mechanical design engineering manager. “Regularly exchanging feedback helps both parties to continuously improve processes and outcomes. Constructive feedback loops allow for adjustments and enhancements that drive project success.”


Empower clients


Collaborating with a knowledgeable CDMO is essential for medtech companies looking to navigate the complexities of product development and manufacturing in a constantly evolving landscape, where keeping up to date with regulations remains critical. By leveraging their extensive expertise and collaborative approach, businesses can enhance their innovative capabilities, streamline production processes and ultimately deliver safer, more effective medical devices to market. With a strong focus on R&D and a commitment to design for manufacturability, Phillips Medisize is a strategic ally that empowers clients to not only meet regulatory demands but also seize new opportunities in an ever-evolving landscape. ●


https://phillipsmedisize.com 31


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100